{"id":3897,"date":"2021-02-13T11:48:48","date_gmt":"2021-02-13T19:48:48","guid":{"rendered":"https:\/\/depts.washington.edu\/pandemicalliance\/?p=3897"},"modified":"2021-02-13T11:48:48","modified_gmt":"2021-02-13T19:48:48","slug":"tocilizumab-in-patients-admitted-to-hospital-with-covid-19-recovery-preliminary-results-of-a-randomised-controlled-open-label-platform-trial","status":"publish","type":"post","link":"https:\/\/depts.washington.edu\/pandemicalliance\/2021\/02\/13\/tocilizumab-in-patients-admitted-to-hospital-with-covid-19-recovery-preliminary-results-of-a-randomised-controlled-open-label-platform-trial\/","title":{"rendered":"Tocilizumab in Patients Admitted to Hospital with COVID-19 (RECOVERY): Preliminary Results of a Randomised, Controlled, Open-Label, Platform Trial"},"content":{"rendered":"<p><i>[pre-print; not peer-reviewed]<\/i> Preliminary results from the RECOVERY trial, a randomized trial conducted among people hospitalized with COVID-19 in Britain, suggest that patients assigned to the interleukin (IL)-6 antibody tocilizumab group were more likely to be discharged from the hospital alive within 28 days than those receiving usual care (54% vs. 47%). Patients in the tocilizumab group were also less likely to require invasive mechanical ventilation or to die than those on usual care (33% vs. 38%).<\/p>\n<p><i>Horby et al. (Jan 11, 2021). Tocilizumab in Patients Admitted to Hospital with COVID-19 (RECOVERY): Preliminary Results of a Randomised, Controlled, Open-Label, Platform Trial. Pre-print downloaded Feb 12 from <\/i><a href=\"https:\/\/www.medrxiv.org\/content\/10.1101\/2021.02.11.21249258v1\">https:\/\/www.medrxiv.org\/content\/10.1101\/2021.02.11.21249258v1<\/a><span class=\"Apple-converted-space\">\u00a0<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>[pre-print; not peer-reviewed] Preliminary results from the RECOVERY trial, a randomized trial conducted among people hospitalized with COVID-19 in Britain, suggest that patients assigned to the interleukin (IL)-6 antibody tocilizumab group were more likely to be discharged from the hospital alive within 28 days than those receiving usual care (54% vs. 47%). Patients in the&#8230;<\/p>\n<div><a class=\"more\" href=\"https:\/\/depts.washington.edu\/pandemicalliance\/2021\/02\/13\/tocilizumab-in-patients-admitted-to-hospital-with-covid-19-recovery-preliminary-results-of-a-randomised-controlled-open-label-platform-trial\/\">Read more<\/a><\/div>\n","protected":false},"author":7,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[6],"tags":[28],"topic":[19],"class_list":["post-3897","post","type-post","status-publish","format-standard","hentry","category-article-summary","tag-treatment","topic-testing-and-treatment"],"_links":{"self":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/3897","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/comments?post=3897"}],"version-history":[{"count":1,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/3897\/revisions"}],"predecessor-version":[{"id":3898,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/3897\/revisions\/3898"}],"wp:attachment":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/media?parent=3897"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/categories?post=3897"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/tags?post=3897"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/topic?post=3897"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}